⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MPLT News
MapLight Therapeutics, Inc. Common Stock
MPLT Investors Have Opportunity to Join MapLight Therapeutics, Inc. Fraud Investigation with SBS Law
businesswire.com
MPLT
Form 8-K
sec.gov
MPLT
MapLight Therapeutics Announces Positive Topline Results from Phase 2 ZEPHYR Trial of ML-007C-MA in Schizophrenia
globenewswire.com
MPLT
Form 8-K
sec.gov
MPLT
MapLight Therapeutics Announces Changes to Board of Directors
globenewswire.com
MPLT
Form 8-K
sec.gov
MPLT
MapLight Announces Topline Results from Phase 2 IRIS Study for ML-004 in Autism Spectrum Disorder
globenewswire.com
MPLT
Form 8-K
sec.gov
MPLT
Form 8-K
sec.gov
MPLT
MapLight Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
globenewswire.com
MPLT